Bruker Co. (NASDAQ:BRKR) Shares Sold by TD Private Client Wealth LLC

TD Private Client Wealth LLC trimmed its position in shares of Bruker Co. (NASDAQ:BRKR) by 27.1% during the fourth quarter, Holdings Channel reports. The firm owned 2,531 shares of the medical research company’s stock after selling 943 shares during the quarter. TD Private Client Wealth LLC’s holdings in Bruker were worth $148,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of BRKR. Wealth Enhancement Advisory Services LLC lifted its stake in Bruker by 1.4% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 13,287 shares of the medical research company’s stock worth $779,000 after acquiring an additional 177 shares in the last quarter. Arizona State Retirement System boosted its stake in shares of Bruker by 0.7% in the fourth quarter. Arizona State Retirement System now owns 30,725 shares of the medical research company’s stock valued at $1,801,000 after purchasing an additional 222 shares during the period. CIBC Asset Management Inc grew its holdings in shares of Bruker by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 4,233 shares of the medical research company’s stock valued at $248,000 after purchasing an additional 223 shares in the last quarter. UMB Bank n.a. increased its stake in Bruker by 37.5% during the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock worth $53,000 after buying an additional 248 shares during the period. Finally, Blue Trust Inc. lifted its holdings in Bruker by 13.5% during the 4th quarter. Blue Trust Inc. now owns 2,164 shares of the medical research company’s stock worth $127,000 after buying an additional 257 shares in the last quarter. 79.52% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

BRKR has been the topic of a number of recent research reports. Bank of America upped their price objective on Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, December 13th. Stifel Nicolaus reduced their price target on Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a research report on Friday, February 14th. Guggenheim reissued a “buy” rating on shares of Bruker in a research report on Monday, February 24th. UBS Group started coverage on shares of Bruker in a research note on Tuesday, December 10th. They set a “neutral” rating and a $66.00 target price on the stock. Finally, The Goldman Sachs Group upgraded shares of Bruker from a “sell” rating to a “neutral” rating and set a $60.00 price target for the company in a report on Thursday, December 5th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $70.50.

Bruker Trading Down 2.8 %

Shares of Bruker stock opened at $43.24 on Wednesday. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15. The company has a fifty day simple moving average of $51.43 and a 200-day simple moving average of $57.35. The stock has a market cap of $6.56 billion, a price-to-earnings ratio of 56.90, a PEG ratio of 2.16 and a beta of 1.18. Bruker Co. has a 12-month low of $42.70 and a 12-month high of $94.52.

Bruker (NASDAQ:BRKR) last released its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. On average, equities analysts forecast that Bruker Co. will post 2.69 EPS for the current fiscal year.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Shareholders of record on Monday, March 17th will be paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date of this dividend is Monday, March 17th. Bruker’s dividend payout ratio is currently 26.32%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.